Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can
delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment
(AAMI). This study will also evaluate genetic risk and brain structure as potential
predictors of mental decline.